The coronavirus has rebooted every aspect of life as we know it. Across Africa, home-grown ideas and small-scale technological innovations are coming to the fore to help combat it.
It’s 8PM in Johannesburg on March 29, the first Sunday of the lockdown in South Africa, and a team from the University of the Witwatersrand (Wits) is hard at work, not in the comfort of their homes, but at an innovation lab, designing the first two prototypes of a face shield.
Letlotlo Phohole and Moses Mogotlane, the two members of the team, are working on paper and transparent face shield models, with a Perspex headband, and they are doing all of this at a Transnet-sponsored innovation space hosted at Wits; together in thought, but apart in (social) distance.
Their work would use 3D-printers and a laser-cut solution, in coming up with the very first version of a face shield developed by Wits.
Reeling from the disastrous effects of the Covid-19 pandemic, just like any other part of the world, Africa is turning to home-grown solutions such as this to tackle a global problem.
“Design can save the world,” says Dr Randall Paton, one of the engineers in charge of coordinating this project. And for any innovation at this time, speed is paramount.
“I think that innovation, especially of the sort that leaves us with a legacy of new products or ideas, is essential in tackling an issue like the coronavirus crisis,” he adds.
The face shields were initially designed for health workers at Netcare Hospitals, made from a flat pack consisting of two pieces that can rapidly be assembled.
Now, they are producing the face shields in only 90 seconds using die-cutting (cutting chosen shapes from low-strength materials), as opposed to 3D-printing them which takes up to 90 minutes.
“We are also working with the Wits’ UK representative looking at possible collaborations with the University of Edinburg who responded similarly to Wits in the face shield provision to healthcare workers. We are sharing our stories with the aim of learning from their mass production process that we could emulate,” Phohole tells FORBES AFRICA.
This pandemic could very well see innovation going from Africa to the rest of the world.
Another example is Fablab Rwanda, a space for members to turn innovative ideas into products specifically in the hardware and electronics domain based in Kigali, that has produced 3,500 face shields so far as the entry point for personal protective equipment, especially for health workers, and is now working on producing low-cost ventilators in Rwanda.
A manufacturer of industrial robots, YASKAWA, in South Africa, for many years, has been looking into a crystal ball believing robots would come handy at such a time. “Future-oriented solutions won’t merely be an option, but an absolute necessity,” they say.
Robotics and automation technology are already playing a pivotal role in the health sector, from the use of automated laboratory tests to autonomous disinfectors utilized in hospitals, but they’re about to extend further into other industries faster than anyone could have anticipated.
The global Japanese manufacturer’s southern African branch has already installed over 2,500 robots in the automotive, manufacturing and packaging industries. Decades ago, YASKAWA proposed the innovative concept of an unmanned factory termed ‘Mechatronics’. Since then, the concept has evolved into ‘i³-Mechatronics’, featuring further advancements and implementation of automation through the management of digital data.
“The fast-moving consumer goods and food markets, however, should see an increase and acceptance in the usage of robots and automation technologies… And this is where robotics could come in to reduce contact and cross-contamination,” says Kurt Rosenberg, Managing Director of YASKAWA Southern Africa.
Covid-19 is birthing a new era of health-focused robots and tech to be used in all spheres of life.
Rosenberg believes a robot-powered workforce is the way to the future, both locally and internationally.
And there are more such examples of blue sky thinking.
In South Africa, construction company Profica has partnered with ‘temporary infrastructure specialists’ Chattels to construct temporary Covid-19 triage and testing facilities.
Chattels have already constructed new temporary Covid-19 triage and potential field hospitals at Tygerberg Hospital, Victoria Hospital and Paarl Hospital in the Western Cape province of South Africa.
Meanwhile in South Africa’s North West province, in Mogwase, a company called Akim Holdings Pty Ltd has designed a walk-through sanitizing unit. With an engineering company, it has created a tunnel that is practical and adjustable to suit the specifications of clients.
“Covid-19 is an introduction to a world hygiene awareness program that many have not been practicing or have partially practiced. The sanitizer tunnel was created with health risks involved especially for hypersensitive individuals and to also accommodate the disabled and parents with prams, providing a ramp and sprayers that release 5-10ml of sanitizer per person,” says Thuli Mabebo, one of the directors of Akim.
Corona contact-tracing is also an area where technology and manpower meet.
According to the Johns Hopkins Bloomberg School of Public Health in Maryland in the United States (US), contact-tracing is key to reopening the economy.
The world’s tech giants Apple and Google have joined forces to unveil plans to build contact-tracing technology with the potential to cover the vast majority of smartphones currently in use across the world. In a joint statement, the companies explained they will develop technology-enabling governments and public health agencies to develop apps to track the pandemic, “with user privacy and security central to the design”. They have decided to refer to it as “exposure notification”.
Closer home, one of the entrepreneurs working on a contact-tracing device app is 2020 FORBES AFRICA 30 Under 30 list-maker, Olajumoke Oduwule, with her company KJK Africa in Nigeria. The ‘DISTANCING App’ ensures the user can observe a six-feet distance with others to control the spread of infectious diseases.
2018 FORBES AFRICA 30 Under 30 list-maker Roger Boniface and his brother Dean, have been working alongside the Aurum Institute, architects, 3D-printers and branding specialists to build automated wash-bins called Shesha Geza. It is a cost-effective mobile wash-bin and sanitizing solution that can service large numbers of people. Boniface plans to install these in high-density areas such as taxi ranks and plans to “sanitize more than 100K hands a day”.
Communications solutions provider, Liquid Telecom, is also coming up with digital solutions for Africa during the pandemic. It has provided solutions for remote learning at Kibabii virtual school in Kenya, established Covid-19 toll-free helplines in Zimbabwe, and provided better connectivity across the East African Community.
The Council for Scientific and Industrial Research (CSIR) in South Africa is also pushing the boundaries of innovation, using an app developed for rhino poaching to tackle Covid-19. Cmore allows rangers to use their cellphones to track poaching incidents, sightings, carcass locations, or to track rangers out on patrol. Now, it is being used to record screening data and assist in tracking potential coronavirus cases. “Community health workers have to enter information on a cellphone and, when they press submit, the cellphone sends a location – not just to the person that has been screened – and that location pins itself on the screen at the CSIR, so we know where we have covered the country with our screens,” says Salim Abdool Karim, chairperson of the Covid-19 ministerial advisory group, during an event just before the lockdown at the University of KwaZulu-Natal in South Africa.
As cases spike in South Africa, Evolutio, an African company whose cloud solutions include BSS/OSS and CRM, has developed artificial intelligence (AI)-powered Covid-19 screening software that will allow the system to identify Covid-19, pneumonia and tuberculosis on chest x-rays, or a photo of the x-ray, in the absence or presence of pathological findings. “Our results from reading thousands of x-rays has showed that the system can achieve an accuracy comparable to radiologists, above 90% sensitivity and above 80% specificity across conditions,” says Evolutio’s co-founder Sunil Menon. However, he says the regulatory authorities have not responded to most Covid-19-related initiatives so they have faced challenges with any local traction.
This is an issue encountered by most innovative players in the fray. Some local manufacturers of Covid-19 test kits claim the regulatory authorities are stifling the distribution and export of kits despite massive demand globally. It will take a while before legislation can approve certain home-based innovations; as a result, it is global innovations that seem to be thriving in Africa.
An ad hoc team of engineers and doctors from the MIT Emergency Ventilator (E-Vent) Project, has developed a low-cost, open-source alternative of ventilators to assist hospitals across the world facing shortages. The goal of the project has been to find a way to automate resuscitator bags using mechanical paddles that continuously, precisely and gently squeeze the sides of the bag. Instead of relying on someone’s hands to manipulate the bag and deliver oxygen, the idea is that this device could do it automatically, and act as a long-term ventilator.
‘A Game Of Survival, Not Growth’
Small businesses all over the world are succumbing to the pandemic.
“90% of the small businesses went from trading on amonthly, weekly, or daily basis, to zero,”– Mashudu Modau
Latest research from fintech group Yoco shows small business revenues in South Africa have plunged over 84% in the pandemic.
“This pandemic has been the ultimate disruptor,” says Mashudu Modau, an entrepreneurship enthusiast and founder of Founders Sauce. Formally working as the community and partnerships manager at Yoco, he was one of many retrenched globally in the pandemic.
“[Covid-19] reduced the number of small businesses that were trading by 90%,” says Modau. “This meant 90% of the small businesses went from trading on a monthly, weekly, or daily basis, to zero.”
Many small businesses operating in Africa already face challenges such as not being registered, lack of resources or lack of funding and as a result, the lockdown has crippled the SMME economy.
“Informal economy businesses were completely wiped out, where they could not trade at all and those that were left operating could not trade at a significant level,” he adds.
Only essential workers or businesses deemed essential services could operate during the lockdown in South Africa. As a result, many businesses are relying on digital platforms to survive if they can afford it, and if lucky, with a client base still consuming their products. Most have had to come up with new ideas. Like startup Granadilla which went from swimwear to grocery delivery in weeks. South African brand Tshepo Jeans, known for denim clothing, quickly pivoted to producing fashionable denim masks. Falke, a South African company once known as a sock manufacturing company, has now turned towards manufacturing face masks from its facility in Pretoria.
With hospitals around the world facing shortages of personal protective equipment (PPE), businesses have stepped up. Nike, for example, has manufactured full face shields and powered, air-purifying respirator (PAPR) lenses to protect against the virus, while the Prada group has started the production of 80,000 medical overalls and 110,000 masks to be allocated to healthcare personnel. Food and beverage company Nestlé is contributing masks and other PPE to frontline workers. It’s also donating medical equipment to hospitals in Burkina Faso, Côte d’Ivoire, Ghana and Senegal. Additionally, in Burkina Faso, it will donate three ventilators, for use in intensive care units.
“Zimbabwe is in the midst of a crisis knowing exactly that its healthcare system is dilapidated…The fact that there is limited supply of hospital equipment in our institutions, especially in this part of the globe, has had a negative effect on our motivation to report for work,”– Dr Masimba Dean Ndoro
The lockdown regulations have also grounded the construction sector.
Siphelele Mngaza, the Founder and CEO of Hannah Properties in South Africa, had to curtail operations, resulting in many clients pulling out of contracts. However, this has made him rethink his building strategy, especially in crowded areas.
“Social distancing and self-quarantine is almost impossible because shacks can [heat] up to about 50 degrees in summer and be really cold in winter with no electricity and no water,” he says. The key then is how to build better cities suitable for everyone.
He emphasizes the importance of having smoother surfaces, greener buildings that incorporate plants, better ventilation and access to natural light. “[Post the pandemic] I envision healthier buildings that behave like plants,” says Mngaza.
On the other side of the spectrum, businesses operating in the digital space have seen a boom at this time. Twenty-eight-year-old entrepreneur Cleo Johnson has taken full advantage of this. She is the founder of Nuecleo, a hospitality and marketing consultancy in South Africa. With clients based in Africa and overseas, she has been able to put together post-corona marketing plans remotely.
“The big thing is, ‘what is your business going to look like post corona?’ Because it is not going to be the same,” she tells FORBES AFRICA. She remains optimistic.
“As a business owner, taking care of yourself mentally is extremely important as it also gives you clarity on a way forward. There is time now to refine your business, your growth strategy and how you can scale your business.”
Those that grab the opportunities or gaps in this pandemic stand a better chance of surviving because if a small business does not receive any revenue within 30 days, it may die, says Modau.
“Right now, it’s a game of survival, not necessarily growth,” he adds.
Where Africa Stands In Healthcare
In Zimbabwe, Dr Masimba Dean Ndoro is a medical doctor on the frontline, working in the country’s Parirenyatwa Group of Hospitals. Wearing his white coat and stethoscope, every day, Ndoro prepares himself for the worst.
“Zimbabwe is in the midst of a crisis knowing exactly that its healthcare system is dilapidated,” he tells FORBES AFRICA. He says Zimbabwe was not ready for the devastation wreaked by Covid-19 on its economy and people. “The fact that there is limited supply of hospital equipment in our institutions, especially in this part of the globe, has had a negative effect on our motivation to report for work.”
March 20 marked the first confirmed case of the virus in Zimbabwe, when a 38-year-old man arrived at his home in Victoria Falls after a trip to Manchester in the UK.
By the end of April, there were 29 confirmed cases and four deaths, a small number compared to neighboring South Africa, but with huge repercussions nevertheless.
With Zimbabwe’s economy on its knees and socioeconomic problems lingering, healthcare in the country was already in dire straits. In an effort to curb the virus, the country was put on lockdown.
Coronavirus testing rolled out. But Ndoro believes this is not enough.
“There has been an outcry for the need to decentralize centers for testing so we reach containment faster. It’s so unfortunate relevant authorities are lagging behind,” he laments.
In Malawi too, efforts to curb the virus have been challenging. The nation is divided. Since the first case of the virus hit headlines in the country on April 2, it was met with skepticism by many in a nation not used to epidemics. For a country that recently nullified its 2020 elections, the public’s trust in the government also reportedly declined. Being told to stay at home and stop business because of an invisible opponent was the least of many citizens’ worries amidst the political instability.
By April 7, the country had recorded its first Covid-19 death. Panic ensued, and the president declared a national disaster. Part of the nation began practicing social distancing despite the Malawi High Court putting in an injunction against the notion of a 21-day lockdown.
On May 5, thousands in Malawi took to the streets in support of the opposition party alliance as they submitted their presidential candidate nomination in Blantyre. It was a sea of red.
“It’s like all they care about is to vote, then start the fight against Covid-19,” a Malawian citizen tells FORBES AFRICA. He watched the crowds chant and dance. “The pandemic is here, and it is real. But we Malawians, we are taking it for granted,” says another to us.
Amid all the chaos, one of the many at the helm in the fight against the virus in Malawi is Dr Titus Divala, a medical doctor and epidemiologist.
Operating from the southern part of the country in the city of Blantyre, he works for the University College of Medicine focusing on malaria, HIV, and tuberculosis, but now, is also part of the national committee leading efforts surrounding the management of the Covid-19 pandemic.
“One thing I have learned as a medical doctor and epidemiologist, I never thought I would come across something that consumes my every thought,” he tells FORBES AFRICA.
“For countries like ours, where we are sort of struggling to get hold of every case, what will happen is the virus will spread widely to most of the population and then at some point, it may not be able to move forward because most of the population is already infected. This is a point we call ‘herd immunity’.”
However, there is one key advantage Malawi and other African countries may have over Covid-19 and that is a young population. It is quite possible the risk of death is slightly lower than that of an older European or American population. However, according to Divala, if a vaccine is found, it may take long to reach African countries due to political and economic challenges.
Further up the continent, in Nigeria, Dr Nneka Mobisson, provides healthcare support for her clients digitally.
“I realized that we as Africans were not willing to take ownership of fixing our healthcare systems. We all have a role to play in ensuring the health and happiness of Africa and I hope everyone is willing to take on that responsibility in the post-Covid world,” she tells FORBES AFRICA.
She is the co-founder and CEO of mDoc, a social enterprise that integrates methodologies in quality improvement and behavioral science with web and mobile-based technology to optimize the end-to-end care experience for people living with chronic illnesses. At this time, her patients are most at risk.
In the first week of April, Mobisson lost an acquaintance to Covid-19. “She had been at the Yale School of Public Health when I was there for medical school and was my best friend’s close friend. She was such a champion for public health in the US, a 45-year-old mother of three, so it just hit too close to home,” says Mobisson, who also knows more friends who have tested positive for the disease. She and her team have been working 24/7 to combat the virus – digitally.
Very few healthcare entities have the ability to provide virtual care and at such a time, it puts Mobisson at an advantage.
“We have a responsibility to protect the vulnerable, and we have been knee-deep supporting our members, the general population and health workers with Covid-19 support. We have shut down all our in-person hubs but have ramped up all virtual care support,” she says.
They have built a center locator called Navihealth which helps to reduce the burden of overwhelmed and insufficient hospital systems in the country. Digitally, they have been able to reach thousands.
However, Mobisson says it has not been easy with funding and resources being limited.
“Most of our team is located in Lagos and electricity is not constant which makes the reality of providing 24/7 guidance to people challenging. We fortunately have a redundancy system when generators or fuel are not available but it certainly makes things very expensive.”
What About Other Diseases?
As governments, hospitals and organizations shift all focus to Covid-19, burdening existing healthcare systems, where does it leave patients with other conditions needing critical care?
“Other diseases are suffering now,” says Dr Herbert Longwe, a lab director at ICAP at Columbia University in Pretoria, South Africa.
Liam Klassen, a 19-year-old from South Africa’s KwaZulu-Natal province, experienced this first-hand. After discovering that flesh-eating bacteria had entered a wound in his leg, he was admitted to a hospital 45km away from home. The staff, he says, were too preoccupied treating Covid-19 patients.
“It was very intense being in hospital, with nurses and doctors, and they really wanted me to get out of the hospital as soon as possible. And my wound was very severe,” he says. Anxiety levels remained high for the family as they were not allowed at the hospital due to regulations, what’s worse; they say they didn’t receive adequate communication about what was going on.
“What has happened is, many people are focused on Covid-19 now, and skilled people who were looking at HIV, are now focusing their attention on Covid-19 and the other diseases are being abandoned,” notes Longwe. His work involves doing surveys to measure the impact of HIV, the burden of the disease and the populations that have been affected. Longwe says that there has been a lack of further research and finances being put into other diseases, as a result, the coronavirus has triggered a funding crisis for NGOs when they are needed the most. “People are no longer paying more attention and putting their efforts in writing grants or research proposals on other diseases, for example, TB, HIV and malaria. The focus has dramatically shifted away from those diseases. But those diseases are still killing us. They are still a public health problem,” he adds.
“The initial genome sequencing was costly and time-consuming but efforts are underway to reduce this cost and get faster turnaround time. This will allow us to help those trying to trace the transmission of the disease in South Africa and the continent,”– Peter van Heusden
But on the other hand, the pandemic will expand knowledge in the public health space and grow more human resources and skills. “We are going to draw a lot of knowledge in terms of public health on disease intervention, disease prevention and disease control,” says Longwe.
Hunt For A Vaccine
Billions of dollars are being spent globally to find a vaccine for Covid-19, but the big question is which is the most promising? According to the World Health Organization (WHO), there are over 70 vaccines in the works for Covid-19, but only four of them are already being tested.
The Bill & Melinda Gates Foundation will fund the manufacturing of seven potential vaccines. But it is possible that one or two of these may be successful.
In South Africa, Peter Van Heusden, a bioinformatician focusing on pathogen genomics, is part of a team researching ways to understand the coronavirus. Simply put, he builds and uses software to make sense of genomic material from bacteria, parasites and viruses.
Together with Dr Mushal Allam, a graduate of the South African National Biodiversity Institute (SANBI) and other scientists, they immediately got to work researching the virus in January this year. “My role has been in sequence analysis, that is taking the data from the sequencing process and trying to clean it up and make sense of it, both for this single SARS-CoV-2 genome and to understand the genome in the context of other SARS-CoV-2 genomes worldwide (collected on the GISAID portal),” Van Heusden says.
This work is a breakthrough in understanding Covid-19 in South Africa in the context of the global pandemic. “The initial genome sequencing was costly and time-consuming but efforts are underway to reduce this cost and get faster turnaround time. This will allow us to help those trying to trace the transmission of the disease in South Africa and the continent,” he says. This research will also help in understanding the global diversity of Covid-19 and note any significant changes in the virus.
Madagascar has reportedly found a cure for Covid-19 in an artemisia-based tonic that’s subject to more trials.
Other options being explored globally to treat Covid-19 include new drugs specifically designed to target SARS-CoV-2, as well as repurposed drugs designed to treat a different disease.
One of the oldest treatments being tested, is convalescent plasma. This involves using blood plasma from people who have recovered from Covid-19 and infusing it into patients presenting the disease.
In Pakistan and India, it was reported that Covid-19 patients recovered through this method, although it’s contested.
In short, it’s all hands on deck as countries and corporates come together to find ways to alleviate the disease.
Rebuilding the world
It’s hard to imagine what the world may look like by the end of the year. From healthcare, to retail, media, travel and education, it will no longer be business as usual. Experts are already coming up with strategies to entirely rebuild nations.
“I hope that in the post-Covid or Covid world, we are willing to invest in primary care systems, non-siloed care that focuses on building awareness and health literacy and one that invests in educating, retaining and supporting our healthcare workers at all levels of the system,” says Mobisson.
Sanitizing, social distancing and mask-wearing are the expected new norms, along with remote working and e-learning. Van Heusden fears the worst in a post-corona society. “I fear there will be a lot of trauma. How we deal with that will define the post-Covid-19 world. We might turn inwards and focus on blame and recriminations. Or we might draw on new awareness of how interconnected we all are and draw strength from that,” he says. In a tweet, South African President Cyril Ramaphosa says “the reality is that we are sailing in uncharted waters. There is still a great deal about the epidemiology of the virus that is unknown. It is better to err on the side of caution than to pay the devastating price of a lapse in judgement.”
We are living a textbook example of history as it’s being made, amid uncertainty that will likely not go away for long. The moot question is: will we all live to tell the tale of a pre-and-post Covid-19 world? Only science can answer that.